ERAP1.md
... ...
@@ -15,11 +15,14 @@ nocite: |
15 15
16 16
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
17 17
18
-|Entity|source |frequency (%)|
19
-|:------:|:---------------------:|:-------------:|
20
-|BL |GAMBL genomes+capture|2.08 |
21
-|BL |Thomas cohort | NA |
22
-|BL |Panea cohort | NA |
18
+### BL
19
+[[include:tables/BL_ERAP1.md]]
20
+
21
+### DLBCL
22
+[[include:tables/DLBCL_ERAP1.md]]
23
+
24
+### FL
25
+[[include:tables/FL_ERAP1.md]]
23 26
24 27
## Mutation pattern and selective pressure estimates
25 28
EXOSC6.md
... ...
@@ -14,11 +14,14 @@ nocite: |
14 14
15 15
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
16 16
17
-|Entity|source |frequency (%)|
18
-|:------:|:---------------------:|:-------------:|
19
-|BL |GAMBL genomes+capture|0.46 |
20
-|BL |Thomas cohort | NA |
21
-|BL |Panea cohort | NA |
17
+### BL
18
+[[include:tables/BL_EXOSC6.md]]
19
+
20
+### DLBCL
21
+[[include:tables/DLBCL_EXOSC6.md]]
22
+
23
+### FL
24
+[[include:tables/FL_EXOSC6.md]]
22 25
23 26
## Mutation pattern and selective pressure estimates
24 27
FLYWCH1.md
... ...
@@ -14,11 +14,11 @@ nocite: |
14 14
15 15
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
16 16
17
-|Entity|source |frequency (%)|
18
-|:------:|:---------------------:|:-------------:|
19
-|BL |GAMBL genomes+capture|1.39 |
20
-|BL |Thomas cohort | NA |
21
-|BL |Panea cohort | NA |
17
+### BL
18
+[[include:tables/BL_FLYWCH1.md]]
19
+
20
+### DLBCL
21
+[[include:tables/DLBCL_FLYWCH1.md]]
22 22
23 23
## Mutation pattern and selective pressure estimates
24 24